![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, March 18, 2020 5:52:46 PM
This was what they came up with previously.
Guardion Health Sciences Selected by Malaysian Listed Company to Develop an Immuno-Supportive Formula
Guardion® has signed a Letter of Appointment with Ho Wah Genting Berhad (HWGB) to create a new formula, designed to enhance the immune system.
The formula will be a unique and exclusive brand of HWGB
San Diego, California, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc (“Guardion” or the “Company”) (Nasdaq:GHSI) announced that Ho Wah Genting Berhad (“HWGB”) a Malaysian company listed on the Malaysian Stock Exchange (Industrial Products sector) has selected Guardion to develop an immune- supportive formula for their consumer base. HWGB has contracted Guardion and its recently acquired subsidiary NutriGuard, to develop a proprietary formula to meet the demands of their customers for an immune-supportive product.
Professor Mark McCarty, the original founder of NutriGuard, and now a senior scientist consultant to Guardion, is a leader in the scientific validation of nutrition-based therapies for potentiating the type 1 interferon response to RNA viruses. Boosting type 1 interferon response is believed to blunt the replication of virus cells. Dr McCarty has been tasked with developing this proprietary formula for HWGB.
The formula is designed to provide both immuno-supportive and anti-inflammatory benefits to its users. The formula has not been used nor tested, nor is it intended to specifically address symptoms of the current COVID-19 virus.
Michael Favish, CEO of Guardion Health Sciences, stated “We are pleased to partner with Ho Wah Genting Berhad for the development of a product specifically designed to boost the immune system capability, i.e. type 1 interferon response, to RNA viruses.”
Dato’ Aaron Lim, group CEO for Ho Wah Genting Berhad, commented, “We are anxious to be able to deliver a unique product that can provide a timely and effective immune response to our customer base. I would like to thank Guardion Health Sciences for their assistance and responsiveness to this request and look forward to introducing this much needed product to the market.”
About Guardion Health Sciences, Inc.
Guardion is an ocular health sciences company thar develops, formulates, manufacture and distributes condition-specific medical foods supported by evidence-based protocols. Guardion’s initial medical food product, Lumega-Z, addresses a depleted macular protective pigment, a known risk factor for age-related macular degeneration (“AMD”) and a significant component of functional vision performance. Guardion has also developed a proprietary medical device, the MapcatSF®, which accurately measures the macular pigment density, therefore providing the only two-pronged evidence-based protocol for the treatment of a depleted macular protective pigment. Information and risk factors with respect to Guardion and its business, including its ability to successfully develop and commercialize its proprietary products and technologies, may be obtained in the Company’s filings with the SEC at www.sec.gov.
About VectorVision®
VectorVision® specializes in the standardization of contrast sensitivity, glare sensitivity, low contrast acuity, and ETDRS acuity vision testing. Its patented standardization system provides the practitioner or researcher the ability to delineate very small changes in visual capability, either as compared to the population or from visit to visit. VectorVision®’s CSV-1000 device is considered the standard of care for clinical trials. VectorVision® is a wholly owned subsidiary of Guardion.
Guardion has completed development of the proprietary VectorVision® CSV-2000 standardized contrast sensitivity test and recently introduced the commercial product to the marketplace. The CSV-2000 is the only computer-generated vision testing instrument available that will provide the optical marketplace with the Company’s proprietary, industry-standard contrast sensitivity test, along with a full suite of standard vision testing protocols. The proprietary standardization methodology incorporated into the CSV-2000 includes a patented technology known as AcQviz that automatically and constantly measures and adjusts screen luminance to a fixed standard light level for vision testing.
About NutriGuard
NutriGuard formulates high-quality, scientifically credible nutraceuticals, which are designed to supplement consumers’ diets and assist in the prevention and management of an array of diseases and conditions. NutriGuard uses pharmaceutical standards to establish the safety and efficacy of the products it develops and markets, and also maintains that commitment through rigorous manufacturing and quality assurance programs. Guardion plans to increase NutriGuard’s existing customer base and build on its product platform by making NutriGuard products available to patients directly and through recommendations by their physicians.
Recent GHSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:11:41 PM
- Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor’s Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution • GlobeNewswire Inc. • 05/31/2024 08:33:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/23/2024 08:56:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:54:41 PM
- Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business • GlobeNewswire Inc. • 05/23/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 12:05:23 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/21/2024 12:05:14 PM
- Guardion Health Sciences Announces its Largest Stockholder Has Voted in Favor of Proposals to Sell the Viactiv Business and the Liquidation Plan at the Company’s Special Meeting of Stockholders to be held on May 23, 2024 • GlobeNewswire Inc. • 05/21/2024 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/15/2024 12:42:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:39:34 PM
- Guardion Health Sciences Announces • GlobeNewswire Inc. • 05/13/2024 09:01:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:46:01 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/06/2024 08:01:37 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/06/2024 04:15:26 AM
- Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023 • GlobeNewswire Inc. • 03/29/2024 10:15:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 03:19:56 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 01/31/2024 10:21:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 10:18:13 PM
- Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc. • GlobeNewswire Inc. • 01/30/2024 11:13:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:15:26 PM
- Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023 • GlobeNewswire Inc. • 11/13/2023 09:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:05:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 08:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:48:46 PM
- Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023 • GlobeNewswire Inc. • 08/14/2023 12:15:00 PM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM